Cargando…

Lipid peroxidation products and antioxidants in human disease.

Lipid peroxidation (LPO) is a free radical-related process that in biologic systems may occur under enzymatic control, e.g., for the generation of lipid-derived inflammatory mediators, or nonenzymatically. This latter form is associated mostly with cellular damage as a result of oxidative stress, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, F J, Bosch-Morell, F, Romero, M J, Jareño, E J, Romero, B, Marín, N, Romá, J
Formato: Texto
Lenguaje:English
Publicado: 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533372/
https://www.ncbi.nlm.nih.gov/pubmed/9788902
_version_ 1782129033550495744
author Romero, F J
Bosch-Morell, F
Romero, M J
Jareño, E J
Romero, B
Marín, N
Romá, J
author_facet Romero, F J
Bosch-Morell, F
Romero, M J
Jareño, E J
Romero, B
Marín, N
Romá, J
author_sort Romero, F J
collection PubMed
description Lipid peroxidation (LPO) is a free radical-related process that in biologic systems may occur under enzymatic control, e.g., for the generation of lipid-derived inflammatory mediators, or nonenzymatically. This latter form is associated mostly with cellular damage as a result of oxidative stress, which also involves cellular antioxidants in this process. This article focuses on the relevance of two LPO products, malondialdehyde (MDA) and 4-hydroxynonenal (HNE), to the pathophysiology of human disease. The former has been studied in human serum samples of hepatitis C virus-infected adults and human immunodeficiency virus-infected children. In these two cases it is shown that the specific assay of serum MDA is useful for the clinical management of these patients. The presence of MDA in subretinal fluid of patients with retinal detachment suggests the involvement of oxidative stress in this process. Moreover, we were able to report the dependence of this involvement on the degree of myopia in these patients. The assay of MDA contents in the peripheral nerves of rats fed a chronic alcohol-containing diet or diabetic mice also confirms the pathophysiologic role of oxidative stress in these experimental models. In these two cases, associated with an increase in tissue LPO products content, we detected a decrease of glutathione peroxidase (GSHPx) activity in peripheral nerve, among other modifications. We have demonstrated that in vitro HNE is able to inhibit GSHPx activity in an apparent competitive manner, and that glutathione may partially protect and/or prevent this inactivation. The accumulation of LPO products in the brain of patients with Alzheimer's disease has also been described, and it is on the basis of this observation that we have tried to elucidate the role of oxidative stress and cellular antioxidants in beta-amyloid-induced apoptotic cell death of rat embryo neurons. Finally, we discuss the possible role of the observed vascular effects of HNE on human arteries.
format Text
id pubmed-1533372
institution National Center for Biotechnology Information
language English
publishDate 1998
record_format MEDLINE/PubMed
spelling pubmed-15333722006-08-08 Lipid peroxidation products and antioxidants in human disease. Romero, F J Bosch-Morell, F Romero, M J Jareño, E J Romero, B Marín, N Romá, J Environ Health Perspect Research Article Lipid peroxidation (LPO) is a free radical-related process that in biologic systems may occur under enzymatic control, e.g., for the generation of lipid-derived inflammatory mediators, or nonenzymatically. This latter form is associated mostly with cellular damage as a result of oxidative stress, which also involves cellular antioxidants in this process. This article focuses on the relevance of two LPO products, malondialdehyde (MDA) and 4-hydroxynonenal (HNE), to the pathophysiology of human disease. The former has been studied in human serum samples of hepatitis C virus-infected adults and human immunodeficiency virus-infected children. In these two cases it is shown that the specific assay of serum MDA is useful for the clinical management of these patients. The presence of MDA in subretinal fluid of patients with retinal detachment suggests the involvement of oxidative stress in this process. Moreover, we were able to report the dependence of this involvement on the degree of myopia in these patients. The assay of MDA contents in the peripheral nerves of rats fed a chronic alcohol-containing diet or diabetic mice also confirms the pathophysiologic role of oxidative stress in these experimental models. In these two cases, associated with an increase in tissue LPO products content, we detected a decrease of glutathione peroxidase (GSHPx) activity in peripheral nerve, among other modifications. We have demonstrated that in vitro HNE is able to inhibit GSHPx activity in an apparent competitive manner, and that glutathione may partially protect and/or prevent this inactivation. The accumulation of LPO products in the brain of patients with Alzheimer's disease has also been described, and it is on the basis of this observation that we have tried to elucidate the role of oxidative stress and cellular antioxidants in beta-amyloid-induced apoptotic cell death of rat embryo neurons. Finally, we discuss the possible role of the observed vascular effects of HNE on human arteries. 1998-10 /pmc/articles/PMC1533372/ /pubmed/9788902 Text en
spellingShingle Research Article
Romero, F J
Bosch-Morell, F
Romero, M J
Jareño, E J
Romero, B
Marín, N
Romá, J
Lipid peroxidation products and antioxidants in human disease.
title Lipid peroxidation products and antioxidants in human disease.
title_full Lipid peroxidation products and antioxidants in human disease.
title_fullStr Lipid peroxidation products and antioxidants in human disease.
title_full_unstemmed Lipid peroxidation products and antioxidants in human disease.
title_short Lipid peroxidation products and antioxidants in human disease.
title_sort lipid peroxidation products and antioxidants in human disease.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533372/
https://www.ncbi.nlm.nih.gov/pubmed/9788902
work_keys_str_mv AT romerofj lipidperoxidationproductsandantioxidantsinhumandisease
AT boschmorellf lipidperoxidationproductsandantioxidantsinhumandisease
AT romeromj lipidperoxidationproductsandantioxidantsinhumandisease
AT jarenoej lipidperoxidationproductsandantioxidantsinhumandisease
AT romerob lipidperoxidationproductsandantioxidantsinhumandisease
AT marinn lipidperoxidationproductsandantioxidantsinhumandisease
AT romaj lipidperoxidationproductsandantioxidantsinhumandisease